75625-99-9,MFCD01722733
Catalog No.:AA0038DN

75625-99-9 | 2-[4-(2-Methylpropenyl)phenyl]propionic Acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
> 95%
2 weeks  
$604.00   $423.00
- +
500mg
> 95%
2 weeks  
$1,381.00   $967.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0038DN
Chemical Name:
2-[4-(2-Methylpropenyl)phenyl]propionic Acid
CAS Number:
75625-99-9
Molecular Formula:
C13H16O2
Molecular Weight:
204.2649
MDL Number:
MFCD01722733
SMILES:
CC(=Cc1ccc(cc1)C(C(=O)O)C)C
Properties
Computed Properties
 
Complexity:
243  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
1  
XLogP3:
3.5  

Literature

Title: Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.

Journal: Journal of medicinal chemistry 20070823

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:75625-99-9 Molecular Formula|75625-99-9 MDL|75625-99-9 SMILES|75625-99-9 2-[4-(2-Methylpropenyl)phenyl]propionic Acid
Catalog No.: AA0038DN
75625-99-9,MFCD01722733
75625-99-9 | 2-[4-(2-Methylpropenyl)phenyl]propionic Acid
Pack Size: 100mg
Purity: > 95%
2 weeks
$604.00 $423.00
Pack Size: 500mg
Purity: > 95%
2 weeks
$1,381.00 $967.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0038DN
Chemical Name: 2-[4-(2-Methylpropenyl)phenyl]propionic Acid
CAS Number: 75625-99-9
Molecular Formula: C13H16O2
Molecular Weight: 204.2649
MDL Number: MFCD01722733
SMILES: CC(=Cc1ccc(cc1)C(C(=O)O)C)C
Properties
Complexity: 243  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 1  
XLogP3: 3.5  
Literature fold

Title: Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.

Journal: Journal of medicinal chemistry20070823

Building Blocks More >
91-33-8
91-33-8
Benzthiazide
AA0038GS | MFCD00078969
58421-79-7
58421-79-7
4-Chloro-6-methylquinazoline
AA0038K4 | MFCD03665203
4296-15-5
4296-15-5
2-Iodoethyl methyl ether
AA0038N6 | MFCD07644549
33105-93-0
33105-93-0
Di-tert-butyl ethane-1,2-diyldicarbamate
AA0038QE | MFCD08694623
196603-96-0
196603-96-0
4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol
AA0038TL | MFCD09955370
110-05-4
110-05-4
Di-tert-butyl peroxide
AA0038WS | MFCD00008803
807334-25-4
807334-25-4
1,2-Ethanediol, 1-phenyl-, 2-carbamate, (1S)- (9CI)
AA003900 | MFCD30491871
503612-47-3
503612-47-3
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide
AA00393U | MFCD11977295
32384-65-9
32384-65-9
(3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2h-pyran-2-one
AA003982 | MFCD22665922
1430219-76-3
1430219-76-3
Potassium trifluoro(oxetan-3-yl)borate
AA0039BP | MFCD24843091
Submit
© 2017 AA BLOCKS, INC. All rights reserved.